UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 124

Sortiert nach

Premenstrual Symptoms and Work: Exploring Female Staff Experiences and Recommendations for Workplaces

International journal of environmental research and public health, 2021-03, Vol.18 (7), p.3647

2021

Link zum Volltext

Verfügbarkeit prüfen

Exploring premenstrual dysphoric disorder (PMDD) in the work context: a qualitative study

Journal of psychosomatic obstetrics and gynaecology, 2017-10, Vol.38 (4), p.292-300

2017

Link zum Volltext

Verfügbarkeit prüfen

Trastuzumab for Patients With Axillary-Node–Positive Breast Cancer: Results of the FNCLCC-PACS 04 Trial

Journal of clinical oncology, 2009-12, Vol.27 (36), p.6129-6134

2009

Link zum Volltext

Verfügbarkeit prüfen

What Are Women Being Exposed to? A Review of the Quality, Content and Ownership of Websites on Premenstrual Dysphoric Disorder

Women's health issues, 2016-03, Vol.26 (2), p.183-189

2016

Link zum Volltext

Verfügbarkeit prüfen

Phase III Trial of Carboplatin Plus Paclitaxel With or Without Gemcitabine in First-Line Treatment of Epithelial Ovarian Cancer

Journal of clinical oncology, 2010-09, Vol.28 (27), p.4162-4169

2010

Link zum Volltext

Verfügbarkeit prüfen

A gemcitabine sensitivity screen identifies a role for NEK9 in the replication stress response

Nucleic acids research, 2014-10, Vol.42 (18), p.11517

2014

Link zum Volltext

Verfügbarkeit prüfen

Weekly paclitaxel, capecitabine, and bevacizumab with maintenance capecitabine and bevacizumab as first‐line therapy for triple‐negative, metastatic, or locally advanced breast cancer: Results from the GINECO A‐TaXel phase 2 study

Cancer, 2016-10, Vol.122 (20), p.3119-3126

2016

Link zum Volltext

Verfügbarkeit prüfen

Bevacizumab plus neoadjuvant chemotherapy in patients with HER2-negative inflammatory breast cancer (BEVERLY-1): a multicentre, single-arm, phase 2 study

The lancet oncology, 2016-05, Vol.17 (5), p.600-611

2016

Link zum Volltext

Verfügbarkeit prüfen

Menopause and the workplace guidance: What to consider

Post reproductive health, 2020-03, Vol.26 (1), p.43-45

Hardy, Claire

2020

Link zum Volltext

Verfügbarkeit prüfen

What do working menopausal women want? A qualitative investigation into women’s perspectives on employer and line manager support

Maturitas, 2017-07, Vol.101, p.37-41

2017

Link zum Volltext

Verfügbarkeit prüfen

Self-help cognitive behavior therapy for working women with problematic hot flushes and night sweats (MENOS@Work): a multicenter randomized controlled trial

Menopause (New York, N.Y.), 2018-05, Vol.25 (5), p.508

2018

Link zum Volltext

Verfügbarkeit prüfen

Prediction of acute myeloid leukaemia risk in healthy individuals

Nature (London), 2018-07, Vol.559 (7714), p.400-404

2018

Link zum Volltext

Verfügbarkeit prüfen

Development and evaluation of online menopause awareness training for line managers in UK organizations

Maturitas, 2019-02, Vol.120, p.83-89

2019

Link zum Volltext

Verfügbarkeit prüfen

Phase II study of the safety and efficacy of the anti-PD-1 antibody balstilimab in patients with recurrent and/or metastatic cervical cancer

Gynecologic oncology, 2021-11, Vol.163 (2), p.274-280

2021

Link zum Volltext

Verfügbarkeit prüfen

Health information work and the enactment of care in couples and families affected by Multiple Sclerosis

Sociology of health & illness, 2019-02, Vol.41 (2), p.395-410

2019

Link zum Volltext

Verfügbarkeit prüfen

Can treatment with Cocculine improve the control of chemotherapy-induced emesis in early breast cancer patients? A randomized, multi-centered, double-blind, placebo-controlled Phase III trial

BMC cancer, 2012-12, Vol.12 (1), p.603-603, Article 603

2012

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of Scores to Reflect Toxicity Impact on Quality of Life of Patients With Platinum-Resistant Ovarian Cancer: AURELIA Substudy

Journal of the National Comprehensive Cancer Network, 2023-05, Vol.21 (5), p.473

2023

Link zum Volltext

Verfügbarkeit prüfen

Development and validation of a prognostic nomogram for overall survival in patients with platinum-resistant ovarian cancer treated with chemotherapy

European journal of cancer (1990), 2019-08, Vol.117, p.99-106

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 124

Suche als RSS-Feed

Aktive Filter

ThemaFemale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(122)
Mit Volltextzugriff
(101)

Publikationsform

Artikel
(124)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(123)
Science & Technology
(114)
Life Sciences & Biomedicine
(110)
Male
(72)
Middle Aged
(68)
Adult
(61)
Aged
(56)
Oncology
(34)
Aged, 80 And Over
(29)
Life Sciences
(25)
Neurosciences & Neurology
(20)
Young Adult
(20)
Adolescent
(19)
Patients
(19)
Clinical Trials
(17)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(15)
Neurosciences
(15)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(14)
General & Internal Medicine
(14)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Premenstrual Symptoms and Work: Exploring Female Staff Experiences and Recommendations for Workplaces

Exploring premenstrual dysphoric disorder (PMDD) in the work context: a qualitative study

Trastuzumab for Patients With Axillary-Node–Positive Breast Cancer: Results of the FNCLCC-PACS 04 Trial

What Are Women Being Exposed to? A Review of the Quality, Content and Ownership of Websites on Premenstrual Dysphoric Disorder

Phase III Trial of Carboplatin Plus Paclitaxel With or Without Gemcitabine in First-Line Treatment of Epithelial Ovarian Cancer

A gemcitabine sensitivity screen identifies a role for NEK9 in the replication stress response

Direct Transcriptional Consequences of Somatic Mutation in Breast Cancer

Weekly paclitaxel, capecitabine, and bevacizumab with maintenance capecitabine and bevacizumab as first‐line therapy for triple‐negative, metastatic, or locally advanced breast cancer: Results from the GINECO A‐TaXel phase 2 study

Bevacizumab plus neoadjuvant chemotherapy in patients with HER2-negative inflammatory breast cancer (BEVERLY-1): a multicentre, single-arm, phase 2 study

Menopause and the workplace guidance: What to consider

CHEOPS trial: a GINECO group randomized phase II assessing addition of a non-steroidal aromatase inhibitor to oral vinorelbine in pre-treated metastatic breast cancer patients

What do working menopausal women want? A qualitative investigation into women’s perspectives on employer and line manager support

Efficacy of maintenance olaparib plus bevacizumab according to clinical risk in patients with newly diagnosed, advanced ovarian cancer in the phase III PAOLA-1/ENGOT-ov25 trial

Self-help cognitive behavior therapy for working women with problematic hot flushes and night sweats (MENOS@Work): a multicenter randomized controlled trial

Prediction of acute myeloid leukaemia risk in healthy individuals

Development and evaluation of online menopause awareness training for line managers in UK organizations

Clinical and biological implications of driver mutations in myelodysplastic syndromes

Phase II study of the safety and efficacy of the anti-PD-1 antibody balstilimab in patients with recurrent and/or metastatic cervical cancer

Health information work and the enactment of care in couples and families affected by Multiple Sclerosis

Can treatment with Cocculine improve the control of chemotherapy-induced emesis in early breast cancer patients? A randomized, multi-centered, double-blind, placebo-controlled Phase III trial

Everolimus Added to Adjuvant Endocrine Therapy in Patients With High-Risk Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Primary Breast Cancer

Expectation about maintenance therapy among the GINECO French ovarian cancer cohort from the European NOGGO/ENGOT-ov22 Expression IV survey

Evaluation of Scores to Reflect Toxicity Impact on Quality of Life of Patients With Platinum-Resistant Ovarian Cancer: AURELIA Substudy

Randomised, open-label, multicentric phase III trial to evaluate the safety and efficacy of palbociclib in combination with endocrine therapy, guided by ESR1 mutation monitoring in oestrogen receptor-positive, HER2-negative metastatic breast cancer patients: study design of PADA-1

Development and validation of a prognostic nomogram for overall survival in patients with platinum-resistant ovarian cancer treated with chemotherapy

Aktive Filter

Suchergebnisse filtern